about
Mechanisms and therapeutic effectiveness of pulsed electromagnetic field therapy in oncologyLyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancerEfficacy, safety and anticancer activity of protein nanoparticle-based delivery of doxorubicin through intravenous administration in ratsDNA methyltransferase inhibitor zebularine inhibits human hepatic carcinoma cells proliferation and induces apoptosisSuppression of AKT anti-apoptotic signaling by a novel drug candidate results in growth arrest and apoptosis of hepatocellular carcinoma cellsProteomic Characterization of Annexin l (ANX1) and Heat Shock Protein 27 (HSP27) as Biomarkers for Invasive Hepatocellular Carcinoma CellsEfficient colonization and therapy of human hepatocellular carcinoma (HCC) using the oncolytic vaccinia virus strain GLV-1h68Docetaxel-loaded lipid microbubbles combined with ultrasound-triggered microbubble destruction for targeted tumor therapy in MHCC-H cellsNoninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions.Bioprocess development for the production of mouse-human chimeric anti-epidermal growth factor receptor vIII antibody C12 by suspension culture of recombinant Chinese hamster ovary cells.Enhanced deacetylation of p53 by the anti-apoptotic protein HSCO in association with histone deacetylase 1.Hedgehog signaling pathway mediates invasion and metastasis of hepatocellular carcinoma via ERK pathway.Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: a meta-analysisInterleukin-37 mediates the antitumor activity in hepatocellular carcinoma: role for CD57+ NK cells.Research on the interaction between tubeimoside 1 and HepG2 cells using the microscopic imaging and fluorescent spectra methodDNA methylation changes in normal liver tissues and hepatocellular carcinoma with different viral infection.Upregulate KIF4A Enhances Proliferation, Invasion of Hepatocellular Carcinoma and Indicates poor prognosis Across Human Cancer Types.Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma.Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma.Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinomaMicroRNA-21 is involved in ionizing radiation-promoted liver carcinogenesis.Epidermal growth factor gene polymorphism and risk of hepatocellular carcinoma: a meta-analysisRelationship between survivin expression and recurrence, and prognosis in hepatocellular carcinomaComparative analysis of cytotoxic T lymphocyte response induced by dendritic cells loaded with hepatocellular carcinoma -derived RNA or cell lysate.RETRACTED: Gene expression profiling analysis of hepatocellular carcinomaGalectin-3 is associated with a poor prognosis in primary hepatocellular carcinomaHighly malignant intra-hepatic metastatic hepatocellular carcinoma in rats.DNA methylation-mediated silencing of matricellular protein dermatopontin promotes hepatocellular carcinoma metastasis by α3β1 integrin-Rho GTPase signaling.The association of HMGB1 expression with clinicopathological significance and prognosis in hepatocellular carcinoma: a meta-analysis and literature review.Potential therapeutic role of Tridham in human hepatocellular carcinoma cell line through induction of p53 independent apoptosisEfficacy and safety of bevacizumab for the treatment of advanced hepatocellular carcinoma: a systematic review of phase II trials.Recent advances in the understanding of the role of the endocannabinoid system in liver diseases.The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States.The significance of Notch1 compared with Notch3 in high metastasis and poor overall survival in hepatocellular carcinoma.Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields.Cancer cell proliferation is inhibited by specific modulation frequenciesMultiple pregnancies, hepatitis C, and risk for hepatocellular carcinoma in Egyptian womenNon-viral factors contributing to hepatocellular carcinoma.GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis.βII-Spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and Wnt signaling by regulation of Wnt inhibitor kallistatin.
P2860
Q28078632-9DFC909D-801D-4414-9153-ACF68A88BDACQ28236063-8F43F772-C5F8-468C-8C03-D47F26155FC3Q28484539-8EBA2484-C22C-4669-BFC8-4F836E36D509Q28484901-B999F8F7-F499-422A-BE7B-E2C5C09CB506Q28485238-2A116549-69EB-4977-B27C-A45E1C720D82Q28550031-807BDE18-5079-4275-9BC1-16F6476D92A2Q28742749-74EC7E77-8BEF-4BF8-B701-FB590FFAF1D4Q30376445-713CD42E-7CF3-4151-A156-00B343F80DB4Q30397191-5AA97E5C-50CF-499F-9884-96F700E05F7AQ30467990-713FAB57-D8A0-4565-8570-EBCADB2FF2A2Q33278013-9D93DAD0-3DA4-4497-B635-8CF9D8F735CBQ33567426-1BB07DE3-E7CC-4A8D-ADFF-F91614466DDFQ33661257-74B3BAB6-A688-454F-9EBC-D815C756342CQ33713444-057B34A9-0194-433A-93E1-1C0A0482409FQ33738107-8CEA5884-ACCB-4079-B3D6-5B6F0C6C4EAFQ33766987-7AC5853A-B851-41A2-8A7E-B46228AF8D62Q33830122-8C10449F-5891-41CB-9104-A6F127985C66Q33855801-03075B04-CF8E-43A4-A4A3-ECF9A160F3B6Q33866389-0E310FEC-F729-4A29-B689-5337336DA082Q34058734-F9163AC7-199D-4B6E-9A07-18A7CBA2AF84Q34091046-0FA6F126-2B30-447D-8500-0E5921239688Q34189361-98392F70-E320-45C6-A31C-D828F4A60D8FQ34225286-8DEF7C3B-9B93-40E5-83B1-02586DC51184Q34231139-503906D2-AA48-43A2-9776-8241535E3F74Q34253636-47CF30A6-AD99-40D5-86D3-16A6A891C990Q34265995-939BBB12-477E-4505-AC48-7A14842B553AQ34310280-C719B556-8F4C-4FA2-83D0-FB301617B592Q34334370-6AEFCA31-2433-42FB-A75B-5667395B5232Q34428389-7B36E386-23C4-4528-BCA5-E985BDD24CF5Q34464794-4F9311C8-C28B-4F97-8765-DECFD6C5D0B5Q34531474-BB07793A-92A7-4862-AD7B-C6CCEC1A20C9Q34550846-E11E212E-3067-40F7-87B2-B704B3D86424Q34601654-C1D05937-0CEE-4C70-9C74-1B468D62A389Q34612059-E6DC99FB-6B20-44A9-85E0-1C45AA020DD4Q34631518-FEF3F2A1-EF60-452A-AF82-B583EE033256Q34634038-5509A9BF-F92F-4F55-9CDA-086237997963Q34649405-C340A28C-1A8C-4FA0-825C-17A78563E159Q34653639-134E632E-89B8-4A30-AA9F-B0D706C176DCQ34693220-51E78164-CE22-4746-8028-C5ED40697874Q35083197-EEAB8A7A-6BA6-4E25-BBDD-F46F9213F222
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Hepatocellular carcinoma: the need for progress.
@ast
Hepatocellular carcinoma: the need for progress.
@en
Hepatocellular carcinoma: the need for progress.
@nl
type
label
Hepatocellular carcinoma: the need for progress.
@ast
Hepatocellular carcinoma: the need for progress.
@en
Hepatocellular carcinoma: the need for progress.
@nl
prefLabel
Hepatocellular carcinoma: the need for progress.
@ast
Hepatocellular carcinoma: the need for progress.
@en
Hepatocellular carcinoma: the need for progress.
@nl
P356
P1476
Hepatocellular carcinoma: the need for progress.
@en
P2093
Andrew X Zhu
Melanie B Thomas
P304
P356
10.1200/JCO.2005.03.196
P407
P577
2005-05-01T00:00:00Z